iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionAbbot Financial Management, Inc.
Latest Disclosed Ownership3,419 shares
Latest Disclosed Value $ 577,298
Abbot Financial Management, Inc. ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 13, 2026 - Abbot Financial Management, Inc. filed a 13F-HR form disclosing ownership of 3,419 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $577,298 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 3,419 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $448,060 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,419 0 0.00 577 0.00 0.2411
2026-02-13 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,419 -25 -0.73 577 16.10 0.2393
2025-11-10 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,444 -20 -0.58 497 13.47 0.2124
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,464 0 0.00 438 -1.13 0.2021
2025-05-07 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,464 -228 -6.18 443 -9.22 0.2299
2025-02-06 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,692 -225 -5.74 488 -14.39 0.2430
2024-11-08 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,917 0 0.00 570 6.15 0.2870
2024-08-09 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,917 0 0.00 538 0.00 0.2880
2024-05-13 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,917 -70 -1.76 537 -0.74 0.2966
2024-02-09 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,987 -184 -4.41 542 6.08 0.3259
2023-11-13 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,171 -400 -8.75 510 -12.07 0.3430
2023-08-14 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,571 -128 -2.72 580 -4.29 0.3724
2023-05-15 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,699 0 0.00 607 -1.62 0.4074
2023-02-09 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,699 -498 -9.58 617 1.32 0.4220
2022-11-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,197 0 0.00 608 -0.49 0.4330
2022-08-09 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,197 0 0.00 611 -9.75 0.3693
2022-05-12 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,197 -400 -7.15 677 -20.73 0.3305
2022-02-15 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,597 0 0.00 854 -5.64 0.3814
2021-11-04 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,597 -50 -0.89 905 -2.06 0.4116
2021-08-05 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,647 0 0.00 924 8.71 0.4039
2021-05-13 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 5,647 -190 -3.26 850 -3.85 0.3857
2021-02-11 2020-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 5,837 -350 -5.66 884 5.49 0.5092
2020-10-26 2020-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,187 100 1.64 838 0.72 0.5438
2020-07-22 2020-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,087 0 0.00 832 26.83 0.5725
2020-05-12 2020-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,087 -50 -0.81 656 -11.35 0.5339
2020-02-12 2019-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,137 -125 -2.00 740 18.78 0.4687
2019-11-13 2019-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,262 0 0.00 623 -8.78 0.4446
2019-08-08 2019-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,262 364 6.17 683 3.64 0.4951
2019-05-15 2019-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 5,898 -90 -1.50 659 14.21 0.5115
2019-02-07 2018-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 5,988 0 0.00 577 -20.96 0.5082
2018-11-09 2018-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 5,988 -144 -2.35 730 8.47 0.5432
2018-08-09 2018-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,132 150 2.51 673 5.32 0.5355
2018-05-02 2018-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 5,982 -175 -2.84 639 -2.74 0.5130
2018-02-12 2017-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,157 4,028 189.20 657 -5.06 0.5237
2017-10-25 2017-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 2,129 -75 -3.40 692 1.32 0.5765
2017-08-11 2017-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY INDEX FUND ETF 464287556 2,204 2,204 683 0.6124
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.